Learn More
Invitrogen™ MyD88 Recombinant Rabbit Monoclonal Antibody (RM306)
Rabbit Recombinant Monoclonal Antibody
Supplier: Invitrogen™ MA527972
Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Myeloid differentiation Marker 88 (MyD88) is an adaptor molecule for the Toll/IL-1R and is involved in the inflammatory response induced by IL-1, IL-18 and LPS. MyD88 recruits IRAK to IL-1 receptor complex in response to IL-1. This pathway further leads to activation of NF-kB. MyD88 has a wide tissue distribution.
Specifications
MyD88 | |
Recombinant Monoclonal | |
0.05 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide | |
Q99836 | |
MYD88 | |
A peptide corresponding to the N-terminus of human MyD88. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Immunohistochemistry (Paraffin), Western Blot | |
RM306 | |
Unconjugated | |
MYD88 | |
mutant myeloid differentiation primary response 88; Myd88; MYD88D; myeloid differentiation primary response 88; myeloid differentiation primary response gene (88); myeloid differentiation primary response gene 88; myeloid differentiation primary response protein MyD88 | |
Rabbit | |
Protein A | |
RUO | |
4615 | |
-20°C | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.